Seasonal Allergy Treatment

Pharmos and Bausch & Lomb


Pharmos and Bausch & Lomb, funded by the BIRD Foundation, developed ‘loteprednol etabonate’ (LE) and this resulted in the fundamental formulation for the development of Lotemax, the No.1 dispensed ophthalmic steroid brand in America, and Alrex, the treatment of choice among many eye-care professionals in the United States for severe seasonal allergic conjunctivitis.